$RGEN
REPLIGEN CORP

2014 Q3 Form 10-Q Financial Statement

#000119312514402643 Filed on November 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2013 Q3
Revenue $15.28M $18.82M
YoY Change -18.83% 24.62%
Cost Of Revenue $6.931M $5.659M
YoY Change 22.48% -11.84%
Gross Profit $8.347M $13.16M
YoY Change -36.59% 51.56%
Gross Profit Margin 54.63% 69.93%
Selling, General & Admin $4.471M $2.902M
YoY Change 54.07% -7.17%
% of Gross Profit 53.56% 22.05%
Research & Development $1.650M $1.430M
YoY Change 15.38% -41.22%
% of Gross Profit 19.77% 10.86%
Depreciation & Amortization $1.100M $760.0K
YoY Change 44.74% -14.61%
% of Gross Profit 13.18% 5.77%
Operating Expenses $6.121M $4.332M
YoY Change 41.3% -22.07%
Operating Profit $2.216M $8.042M
YoY Change -72.44% 267.55%
Interest Expense $11.00K $11.70K
YoY Change -6.02% -267.2%
% of Operating Profit 0.5% 0.15%
Other Income/Expense, Net -$14.00K $37.00K
YoY Change -137.84% -107.4%
Pretax Income $2.255M $8.143M
YoY Change -72.31% 354.92%
Income Tax $789.0K $2.255M
% Of Pretax Income 34.99% 27.69%
Net Earnings $1.466M $5.888M
YoY Change -75.1% 226.02%
Net Earnings / Revenue 9.6% 31.28%
Basic Earnings Per Share $0.04 $0.18
Diluted Earnings Per Share $0.04 $0.18
COMMON SHARES
Basic Shares Outstanding 32.68M shares 31.86M shares
Diluted Shares Outstanding 33.33M shares 32.55M shares

Balance Sheet

Concept 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $54.10M $63.00M
YoY Change -14.13% 107.92%
Cash & Equivalents $35.91M $42.24M
Short-Term Investments $18.20M $20.70M
Other Short-Term Assets $1.200M $1.500M
YoY Change -20.0% 36.36%
Inventory $13.34M $10.06M
Prepaid Expenses
Receivables $7.053M $6.324M
Other Receivables $0.00 $6.600M
Total Short-Term Assets $75.69M $87.44M
YoY Change -13.44% 62.55%
LONG-TERM ASSETS
Property, Plant & Equipment $13.19M $12.29M
YoY Change 7.32% 21.5%
Goodwill $14.14M $994.0K
YoY Change 1322.94% 0.0%
Intangibles $15.35M $6.482M
YoY Change 136.8% -12.13%
Long-Term Investments $10.00M $4.100M
YoY Change 143.9% -66.94%
Other Assets $500.0K $300.0K
YoY Change 66.67% 50.0%
Total Long-Term Assets $53.14M $24.20M
YoY Change 119.63% -22.21%
TOTAL ASSETS
Total Short-Term Assets $75.69M $87.44M
Total Long-Term Assets $53.14M $24.20M
Total Assets $128.8M $111.6M
YoY Change 15.4% 31.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.763M $929.6K
YoY Change 197.2% -47.38%
Accrued Expenses $7.708M $7.855M
YoY Change -1.87% 8.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.47M $8.784M
YoY Change 19.2% -2.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.688M $2.696M
YoY Change 36.8% 41.86%
Total Long-Term Liabilities $3.688M $2.696M
YoY Change 36.8% 41.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.47M $8.784M
Total Long-Term Liabilities $3.688M $2.696M
Total Liabilities $14.16M $11.48M
YoY Change 23.33% 4.97%
SHAREHOLDERS EQUITY
Retained Earnings -$80.49M -$92.38M
YoY Change -12.88% -19.45%
Common Stock $327.0K $318.8K
YoY Change 2.57% 2.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $114.6M $100.2M
YoY Change
Total Liabilities & Shareholders Equity $128.8M $111.6M
YoY Change 15.4% 31.5%

Cashflow Statement

Concept 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income $1.466M $5.888M
YoY Change -75.1% 226.02%
Depreciation, Depletion And Amortization $1.100M $760.0K
YoY Change 44.74% -14.61%
Cash From Operating Activities $6.330M $6.580M
YoY Change -3.8% 166.4%
INVESTING ACTIVITIES
Capital Expenditures -$1.740M -$2.660M
YoY Change -34.59% 731.25%
Acquisitions
YoY Change
Other Investing Activities $20.00K $600.0K
YoY Change -96.67% -161.22%
Cash From Investing Activities -$1.720M -$2.070M
YoY Change -16.91% 60.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -460.0K -170.0K
YoY Change 170.59% -122.37%
NET CHANGE
Cash From Operating Activities 6.330M 6.580M
Cash From Investing Activities -1.720M -2.070M
Cash From Financing Activities -460.0K -170.0K
Net Change In Cash 4.150M 4.340M
YoY Change -4.38% 123.71%
FREE CASH FLOW
Cash From Operating Activities $6.330M $6.580M
Capital Expenditures -$1.740M -$2.660M
Free Cash Flow $8.070M $9.240M
YoY Change -12.66% 231.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.87
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1670688 shares
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42244420
CY2014Q1 us-gaap Security Deposit
SecurityDeposit
450000
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32703113 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32703113 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1169331 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.61
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
480300 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.17
CY2014Q3 us-gaap Share Price
SharePrice
19.91
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
689031 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
7.43
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q3 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
24 Investment
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2824057 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1259317 shares
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
343000
CY2014Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
77000
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13810261
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10470873
CY2014Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1217911
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
327031
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2718884
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2762771
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-80488663
CY2014Q3 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
0
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1371000
CY2014Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
88764
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7708102
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
114585546
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3687591
CY2014Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
426795
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1371000
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128832774
CY2014Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3175915
CY2014Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1137231
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
197466062
CY2014Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
799299
CY2014Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1885202
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
279450
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1371000
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3006731
CY2014Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
840685
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1371000
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10000
CY2014Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
15090
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35906861
CY2014Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1596606
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1171000
CY2014Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2267094
CY2014Q3 us-gaap Goodwill
Goodwill
14144045
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13190868
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15596097
CY2014Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
28177030
CY2014Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
8991000
CY2014Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
18523965
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1159352
CY2014Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
450000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
14681625
CY2014Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
10007186
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1171000
CY2014Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4466549
CY2014Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
52915
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27001129
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
7559847
CY2014Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
18162239
CY2014Q3 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
60505
CY2014Q3 us-gaap Assets
Assets
128832774
CY2014Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
8962
CY2014Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4034523
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1171000
CY2014Q3 us-gaap Inventory Net
InventoryNet
13341783
CY2014Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5721251
CY2014Q3 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
0
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7052908
CY2014Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
7600
CY2014Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
28169577
CY2014Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7637
CY2014Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
18169844
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15348050
CY2014Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
9139408
CY2014Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
13937516
CY2014Q3 us-gaap Assets Current
AssetsCurrent
75692625
CY2014Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
18169844
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1171000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1171000
CY2014Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3153983
CY2014Q3 rgen Available For Sale Securities Debt Maturities One Through Two Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesOneThroughTwoYearsAmortizedCost
10007338
CY2014Q3 rgen Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
10007186
CY2014Q3 rgen Impact Of Credit Risk On Fair Value Of Derivatives
ImpactOfCreditRiskOnFairValueOfDerivatives
0
CY2014Q3 rgen Expected Effective Income Tax Rate For Current Fiscal Year
ExpectedEffectiveIncomeTaxRateForCurrentFiscalYear
0.221 pure
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32721704 shares
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29209821
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31925741 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31925741 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.07
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1610988 shares
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
183000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12287010
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11301171
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2324711
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
319257
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1998330
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1721459
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89057422
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
34012152
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
8592434
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1249824
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
200000
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
184848
CY2013Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
12218602
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2955120
CY2013Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
7591
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9579712
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
103886102
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3457631
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
599784
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
118644904
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2404802
CY2013Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1195248
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
190625937
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
385478
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1648928
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3341
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3166086
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1897473
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10000
CY2013Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4637
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39829653
CY2013Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
21647
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2116017
CY2013Q4 us-gaap Goodwill
Goodwill
994000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12509223
CY2013Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
6730818
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24796233
CY2013Q4 us-gaap Assets
Assets
118644904
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1984
CY2013Q4 us-gaap Inventory Net
InventoryNet
11798638
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4557870
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4946132
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
34017451
CY2013Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
9936
CY2013Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
21793550
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6187632
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
8973615
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
13684954
CY2013Q4 us-gaap Assets Current
AssetsCurrent
86350599
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
23998430
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3774847
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4285648
CY2013Q4 rgen Expected Effective Income Tax Rate For Current Fiscal Year
ExpectedEffectiveIncomeTaxRateForCurrentFiscalYear
0.266 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.19
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
699639 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
18967882
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.43
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32282702 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.44
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
469500 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31583063 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
934280
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
267364
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
37132094
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-264690
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1149997
us-gaap Operating Income Loss
OperatingIncomeLoss
17689521
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13028716
us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
1481000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-2535498
us-gaap Income Taxes Paid
IncomeTaxesPaid
1196000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17798550
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
12194000
us-gaap Royalty Revenue
RoyaltyRevenue
15654919
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-56504
us-gaap Revenues
Revenues
52787013
us-gaap Net Income Loss
NetIncomeLoss
12765697
us-gaap Investment Income Net
InvestmentIncomeNet
203170
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2118953
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
376123
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4345
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
57862000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2442596
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
87648
us-gaap Interest Expense
InterestExpense
37637
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5919265
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9334087
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
46521
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
490267
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
13034599
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5032853
us-gaap Cost Of Goods Sold
CostOfGoodsSold
17854249
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2271181
us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
1943370
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1859151
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-118933
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-7880082
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2235274
us-gaap Costs And Expenses
CostsAndExpenses
35097492
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1529213
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
19893195
us-gaap Share Based Compensation
ShareBasedCompensation
768534
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
376698 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y1M28D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.41
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
REPLIGEN CORP
dei Trading Symbol
TradingSymbol
RGEN
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.12
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.214 pure
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y2M12D
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
807011 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
16647868
us-gaap Basis Of Accounting
BasisOfAccounting
<div> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><b>1.</b></td> <td align="left" valign="top"><b>Basis of Presentation</b></td> </tr> </table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> The consolidated financial statements included herein have been prepared by Repligen Corporation (the &#x201C;Company,&#x201D; &#x201C;Repligen&#x201D; or &#x201C;we&#x201D;) in accordance with generally accepted accounting principles in the United States (&#x201C;U.S. GAAP&#x201D;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201C;SEC&#x201D;), for Quarterly Reports on Form 10-Q and Article 10 of Regulation S-X and do not include all of the information and footnote disclosures required by U.S. GAAP. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#xA0;31, 2013.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments, consisting of only normal, recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows. The results of operations for the interim periods presented are not necessarily indicative of results to be expected for the entire year.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.28
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.49
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M4D
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33099599 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
105831 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.10
dei Entity Central Index Key
EntityCentralIndexKey
0000730272
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.29
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
289475 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
622538 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32292588 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1023136
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4762998
us-gaap Increase In Restricted Cash
IncreaseInRestrictedCash
250000
us-gaap Gain Loss On Investments
GainLossOnInvestments
0
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
45038275
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-88326
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1347340
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
112622
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4717214
us-gaap Operating Income Loss
OperatingIncomeLoss
10629928
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-2640
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3851545
us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
0
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-6677903
us-gaap Income Taxes Paid
IncomeTaxesPaid
671000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10895904
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
1370000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
9890000
us-gaap Royalty Revenue
RoyaltyRevenue
2116841
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
21235937
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
53671
us-gaap Revenues
Revenues
47155116
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
24236256
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2964108
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-4717214
us-gaap Net Income Loss
NetIncomeLoss
8568759
us-gaap Investment Income Net
InvestmentIncomeNet
250659
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
762768
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
603677
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
45784
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
50937000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
261471
us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
2115000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2884175
us-gaap Interest Expense
InterestExpense
38354
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4280987
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12180127
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
126335
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
1246348
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-254587
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1004000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3922792
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2327145
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
us-gaap Cost Of Goods Sold
CostOfGoodsSold
19937739
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2964633
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
882654
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1984539
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-18569139
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1486331
us-gaap Costs And Expenses
CostsAndExpenses
36525188
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
921307
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
30117162
us-gaap Share Based Compensation
ShareBasedCompensation
1385728
rgen Long Term Marketable Securities Maturities Term Minimum
LongTermMarketableSecuritiesMaturitiesTermMinimum
P1Y
rgen Royalty Payment Rate
RoyaltyPaymentRate
0.15 pure
rgen Payment To Be Received Upon Signing Of Agreement
PaymentToBeReceivedUponSigningOfAgreement
125675
rgen Nonrefundable Upfront Cash Payment Under Collaborations Agreement
NonrefundableUpfrontCashPaymentUnderCollaborationsAgreement
2000000
rgen Marketable Securities Remaining Maturity
MarketableSecuritiesRemainingMaturity
P9M14D
CY2014Q1 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P8Y1M
CY2014Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
361000
CY2014Q1 rgen Lease Agreement Area
LeaseAgreementArea
75594 sqft
CY2013 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P8Y
CY2013 us-gaap Gain Loss On Investments
GainLossOnInvestments
0
CY2013Q1 us-gaap Income Tax Expense Benefit Extraordinary Items
IncomeTaxExpenseBenefitExtraordinaryItems
298000
CY2014Q1 rgen Non Contingent Consideration Being Recognized As Revenue Over Estimated Period Of Performance
NonContingentConsiderationBeingRecognizedAsRevenueOverEstimatedPeriodOfPerformance
2000000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
693483 shares
CY2013Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.20
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32551586 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2013Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.20
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
161000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31858103 shares
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1407860
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
12184215
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
8041759
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7298410
CY2013Q3 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
719000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8142779
CY2013Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
6162000
CY2013Q3 us-gaap Royalty Revenue
RoyaltyRevenue
6637838
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
36678
CY2013Q3 us-gaap Revenues
Revenues
18822053
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
5888274
CY2013Q3 us-gaap Investment Income Net
InvestmentIncomeNet
76046
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2276
CY2013Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
20519000
CY2013Q3 us-gaap Interest Expense
InterestExpense
11704
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1429529
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2902048
CY2013Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
65108
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2254505
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5659832
CY2013Q3 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
723777
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
10780294
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
205772
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
650374 shares
CY2014Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.04
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33327377 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2014Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.04
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
263475 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32677003 shares
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3157242
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
15152510
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2216230
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1657288
CY2014Q3 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
0
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2254552
CY2014Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
1848000
CY2014Q3 us-gaap Royalty Revenue
RoyaltyRevenue
125675
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14113
CY2014Q3 us-gaap Revenues
Revenues
15278185
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
1466236
CY2014Q3 us-gaap Investment Income Net
InvestmentIncomeNet
63924
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
33718
CY2014Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
15278000
CY2014Q3 us-gaap Interest Expense
InterestExpense
11489
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1649864
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4470682
CY2014Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
10315
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
788316
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6931094
CY2014Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
13061955
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
533092
CY2012Q4 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
3021000

Files In Submission

Name View Source Status
0001193125-14-402643-index-headers.html Edgar Link pending
0001193125-14-402643-index.html Edgar Link pending
0001193125-14-402643.txt Edgar Link pending
0001193125-14-402643-xbrl.zip Edgar Link pending
d802849d10q.htm Edgar Link pending
d802849dex311.htm Edgar Link pending
d802849dex312.htm Edgar Link pending
d802849dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgen-20140930.xml Edgar Link completed
rgen-20140930.xsd Edgar Link pending
rgen-20140930_cal.xml Edgar Link unprocessable
rgen-20140930_def.xml Edgar Link unprocessable
rgen-20140930_lab.xml Edgar Link unprocessable
rgen-20140930_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending